General Information of DTT (ID: TT5ZWB6)

DTT Name Dihydrodiol dehydrogenase type I (AKR1C3) DTT Info
Gene Name AKR1C3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flufenamic Acid DMC8VNH Dysmenorrhea GA34.3 Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ASP-9521 DM8V0UL Prostate cancer 2C82.0 Phase 1/2 [2]
------------------------------------------------------------------------------------
13 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-naphthylacetic acids derivative 1 DM5KTDY N. A. N. A. Patented [3]
Indomethacin analog 1 DM3E5V6 N. A. N. A. Patented [3]
Indomethacin analog 2 DMKFPJ7 N. A. N. A. Patented [3]
Indomethacin analog 3 DM53JXE N. A. N. A. Patented [3]
Isoquinolone derivative 1 DMW6R0H N. A. N. A. Patented [3]
N-(benzimidazole/indole) benzoic acid derivative 1 DMGQWKH N. A. N. A. Patented [3]
N-(benzimidazole/indole) benzoic acid derivative 2 DMOPUFM N. A. N. A. Patented [3]
N-(benzimidazolylcarbonyl)-piperidine derivative 1 DM541QW N. A. N. A. Patented [3]
N-(indolylcarbonyl)-piperidine derivative 1 DMARHJ9 N. A. N. A. Patented [3]
N-(naphthylamino)-benzoate derivative 1 DM310ES N. A. N. A. Patented [3]
N-(phenylamino)-benzoate derivative 1 DMNIWVG N. A. N. A. Patented [3]
N-(pyridinepyrroylylcarbonyl)-piperidine derivative 1 DMA85UD N. A. N. A. Patented [3]
Nitrogen/sulfur-substituted estrene derivative 1 DMD7OW0 N. A. N. A. Patented [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Patented Agent(s)
15 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2'-Monophosphoadenosine 5'-Diphosphoribose DME9S8M Discovery agent N.A. Investigative [4]
2,2-Dibenzylcyclopentanol DMFPYU8 Discovery agent N.A. Investigative [5]
2-(4-Chlorobenzylidene)cyclopentanone DMOH2YC Discovery agent N.A. Investigative [5]
2-(4-chlorobenzylidene)cyclopentyl ethyl ether DMFE93N Discovery agent N.A. Investigative [5]
2-(4-chlorobenzylidene)cyclopentylmethyl ether DMTW9B7 Discovery agent N.A. Investigative [5]
2-Methyl-2,4-Pentanediol DMD45CU Discovery agent N.A. Investigative [4]
2-[(2,2-diphenylacetyl)amino]benzoic acid DMVSTG7 Discovery agent N.A. Investigative [6]
3-Bromo-5-phenylsalicylc acid DMZTDCL Discovery agent N.A. Investigative [7]
3-Phenylcyclopentanecarboxylic acid DMJOD1T Discovery agent N.A. Investigative [5]
4-ANDROSTENE-3-17-DIONE DMSE8NU Discovery agent N.A. Investigative [4]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [4]
EM-1424 DMSLHDN Discovery agent N.A. Investigative [8]
EM1396 DMZ2EL1 Discovery agent N.A. Investigative [8]
M-Phenoxybenzoic Acid For Cis-Isomer DMJRK47 Discovery agent N.A. Investigative [6]
Rutin DMEHRAJ Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Ouellet M, Percival MD: Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem J. 1995 Feb 15;306 ( Pt 1):247-51.
2 Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study. Invest New Drugs. 2014 Oct;32(5):995-1004.
3 Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Dec;27(12):1329-1340.
4 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
5 New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3. Eur J Med Chem. 2009 Jun;44(6):2563-71.
6 Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of ant... Bioorg Med Chem Lett. 2005 Dec 1;15(23):5170-5.
7 Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20... J Med Chem. 2009 May 28;52(10):3259-64.
8 Structure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenase. J Biol Chem. 2007 Mar 16;282(11):8368-79.